![Naprod Pantoprazole](https://www.pharmacompass.com/image/flap/naprod-pantoprazole-sodium-desktop-headergif-18036.gif)
![Naprod Pantoprazole](https://www.pharmacompass.com/image/flap/naprod-pantoprazole-sodium-mobile-headergif-5608.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
Details:
Pantoprazole Sodium Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD and Pathological Hypersecretory Conditions.
Lead Product(s): Pantoprazole Sodium
Therapeutic Area: Gastroenterology Product Name: Protonix-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 13, 2023
Details:
Sandoz has shipped pantoprazole sodium for injection, 40 mg to Civica Rx to supply the hospitals it serves as part of a multiyear collaboration to help reduce supply shortages, with several other medicines on the way before the end of the year.
Lead Product(s): Pantoprazole Sodium
Therapeutic Area: Gastroenterology Product Name: Pantoprazole Sodium-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Civica Rx
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration November 02, 2020